Phase 2 Epilepsy Clinical Trial Update

Phase 2 Epilepsy Clinical Trial Update

August 16, 2017

PhytoTech Therapeutics’ first Phase 2 clinical trial, which commenced in February 2017, is continuing as planned. This clinical trial is an open-label study aimed at evaluating the safety, tolerability and efficacy of oral administration of PTL101 as an adjunctive treatment for children with refractory epilepsy. The PTL101 drug beads are utilising proprietary formulation developed through […]

Haywood Securities Research Report

Haywood Securities Research Report

July 3, 2017

Read the Haywood Securities investment report